Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kull

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 6, 2010
Catalytic asymmetric synthesis of trans-configured beta-lactones: cooperation of Lewis acid and ion pair catalysisThomas Kull, José Cabrera, René Peters
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planningThomas Kull, P Kletting, S N Reske, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D modeThomas Kull, Jochen Ruckgaber, Rolf Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Chirurgische Behandlung von Melanomen in der Schwangerschaft: eine praktische AnleitungDiana Crisan, Nicolai Treiber, Thomas Kull, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Surgical treatment of melanoma in pregnancy: a practical guidelineDiana Crisan, Nicolai Treiber, Thomas Kull, et al.
Medical Physics|July 23, 2011
Optimal preloading in radioimmunotherapy with anti-cD45 antibodyPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE TherapyPeter Kletting, Thomas Kull, Christian Maaß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic modelPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Medical Physics|May 12, 2017
Internal radionuclide therapy: The ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 6, 2010
Catalytic asymmetric synthesis of trans-configured beta-lactones: cooperation of Lewis acid and ion pair catalysisThomas Kull, José Cabrera, René Peters
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2011
Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planningThomas Kull, P Kletting, S N Reske, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D modeThomas Kull, Jochen Ruckgaber, Rolf Weller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Chirurgische Behandlung von Melanomen in der Schwangerschaft: eine praktische AnleitungDiana Crisan, Nicolai Treiber, Thomas Kull, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2016
Surgical treatment of melanoma in pregnancy: a practical guidelineDiana Crisan, Nicolai Treiber, Thomas Kull, et al.
Medical Physics|July 23, 2011
Optimal preloading in radioimmunotherapy with anti-cD45 antibodyPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2015
Optimized Peptide Amount and Activity for ⁹⁰Y-Labeled DOTATATE TherapyPeter Kletting, Thomas Kull, Christian Maaß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic modelPeter Kletting, Thomas Kull, Donald Bunjes, et al.
Medical Physics|May 12, 2017
Internal radionuclide therapy: The ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Pageof 2